OPA1 gene and mitochondrial optic neuropathy: disease mechanisms and potential therapies

E-ISSN： 1755-3768|94|S256|j.1755-3768.2016.0044-j.1755-3768.2016.0044

ISSN： 1755-375X

Source： ACTA OPHTHALMOLOGICA, Vol.94, Iss.S256, 2016-10, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leber hereditary optic neuropathy (LHON): a mitochondrial disease with unresolved complexities

Cytogenetic and Genome Research, Vol. 86, Iss. 2, 1999-10 ,pp. : 153-156

Karger

Access to resources Recommend Favorite

A high-density transcript map of the human dominant optic atrophy OPA1 gene locus and re-evaluation of evidence for a founder haplotype

Cytogenetic and Genome Research, Vol. 92, Iss. 1-2, 2001-04 ,pp. : 97-102

Karger

Access to resources Recommend Favorite

Personalised therapies for mitochondrial optic neuropathies – myth or reality?

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

OPA1 analysis in an international series of probands with bilateral optic atrophy

ACTA OPHTHALMOLOGICA, Vol. 94, Iss. S256, 2016-10 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Connexin37: a potential modifier gene of inflammatory disease

By Chanson Marc Kwak Brenda

Journal of Molecular Medicine, Vol. 85, Iss. 8, 2007-08 ,pp. : 787-795

Springer Publishing Company

Access to resources Recommend Favorite